Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
for
Recurrent Glioblastoma IDH Wildtype
Location: Durham NC
Sponsor: Darell Bigner
Sex: All
Age: 18+
Code: NCT06455605
Phase 1, Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Durham NC, Roanoke VA, Charlotte NC, Richmond VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Durham NC, Chapel Hill NC, Hillsborough NC,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension,
Location: Durham NC
Sponsor: Bastiaan Driehuys
Sex: All
Age: 18 - 70+
Code: NCT06104228
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Durham NC, Greenville NC, Washington D.C. DC,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase 3, Recruiting
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
for
Spinal Injuries, Spinal Deformity
Location: Durham NC, Louisville KY, New York NY, San Francisco CA
Sponsor: Columbia University
Sex: All
Age: 18 - 70+
Code: NCT02314988
Phase 2, Phase 3, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
for
Glycogen Storage Disease Type Ia
Location: Durham NC, Philadelphia PA, Ann Arbor MI, Hartford CT,
Sponsor: Ultragenyx Pharmaceutical Inc
Sex: All
Age: 2+
Code: NCT06636383
Recruiting
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
for
Breast Cancer, Breast Cancer Female,
Location: Durham NC, Boston MA, Miami FL
Sponsor: Nancy Lin, MD
Sex: All
Age: 18+
Code: NCT06176261
Phase 2, Recruiting
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
for
Neutropenia
Location: Durham NC, Philadelphia PA, Atlanta GA, Cincinnati OH,
Sponsor: X4 Pharmaceuticals
Sex: All
Age: 12+
Code: NCT06056297
Phase 3, Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
for
Pompe Disease
Location: Durham NC, Fairfax VA, Pittsburgh PA, Philadelphia PA,
Sponsor: Amicus Therapeutics
Sex: All
Age: 0+
Code: NCT06121011
Recruiting
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)